Cooley’s Regulatory Immersion Roundtable Series is an invitation-only series for senior company executives and investors. It is designed to provide insight, real-life examples and practical tips for addressing the most significant legal and compliance topics relevant to pharmaceutical, biotechnology and medical device companies in late stage development or early commercialization.
Please join Cooley’s health regulatory experts and fellow executives for an informal, interactive discussion.
This session will provide an update on the health policy of the new administration, introduce you to the key players on the relevant Congressional committees and examine the potential health legislative agendas. While there is much that will be characterized as TBD, we will discuss potential winning and losing sectors. We also will discuss what to watch, when to watch it and what it could mean for business models. This discussion will include practical strategies for conducting business in an uncertain regulatory environment.
Wendy Goldstein – Partner, Cooley
Vince Sampson – Special Counsel, Cooley
Cooley LLP certifies that this activity has been approved for MCLE credit by the State Bar of California in the amount of 2.0 hours.
Cooley LLP is a MCLE approved activity provider. Cooley LLP has been certified by the New York State Continuing Legal Education Board as an Accredited Provider of continuing legal education in the State of New York (1/1/2016 – 12/31/2018).
NY CLE Credit: 2.0 credits in professional practice.
The format of this program provides non-transitional and transitional credit.
The content of this course is appropriate for both newly admitted and experienced lawyers. Visit Cooley's Healthcare Regulatory Blog, TheBeat@CooleyHealth, for additional resources and information.
For more information, please email Leah Lowery.